Scientific Sessions 2025  /  Inflammation and Atherosclerosis: Smoldering Threat or Therapeutic Target?  /  Beyond Lipids: The Current and Future Landscape of Anti-Inflammatory Therapies for ASCVD
Logo

American Heart Association

  38
  0

Final ID:

Beyond Lipids: The Current and Future Landscape of Anti-Inflammatory Therapies for ASCVD

  • Ridker, Paul  ( BRIGHAM WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Ballantyne, Christie  ( BAYLOR COLLEGE MEDICINE , Houston , Texas , United States )
    • Author Disclosures:
    Paul Ridker: DO have relevant financial relationships ; Research Funding (PI or named investigator):Kowa, Novartis, Pfizer, NovoNordisk:Active (exists now) ; Advisor:Uppton, Bitteroot Bio, Angiowave, Peter Munk University of Toronto, Leducq Foundation:Active (exists now) ; Consultant:Novartis, Novo Nordisk, Agepha, Ardelyx, Arrowhead, AstraZeneca, CSK Behring, Civi Biopharm, GSK, Eil Lilly, New Amsterdam, CardioTherapeutics, Caristo, Tourmaline Bio:Active (exists now) | Christie Ballantyne: DO have relevant financial relationships ; Researcher:merck:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Researcher:Novo Nordisk:Active (exists now) ; Consultant:Arrowhead:Active (exists now) ; Researcher:Arrowhead:Active (exists now) ; Consultant:Ionis:Active (exists now) ; Researcher:Ionis:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Researcher:Amgen:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Researcher:Eli Lilly:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Consultant:Merck:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Inflammation and Atherosclerosis: Smoldering Threat or Therapeutic Target?

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Debate: Seeing the Fire or Measuring the Smoke? The Battle for Superior Risk Stratification: Inflammatory Biomarkers

Antoniades Charalambos, Fayad Zahi

The Fire Within – Inflammation as a Cardiovascular Risk Driver

Mora Samia, Libby Peter

More abstracts from these authors:
Emerging Therapies in AMI: Targeting Inflammation and Microvascular Obstruction

Ridker Paul

Canakinumab - can it find a role for CAD?

Ridker Paul

You have to be authorized to contact abstract author. Please, Login
Not Available